PL368079A1
Substituted oxazolidinones for combinational therapy
Abstract
The invention relates to combinations of A) oxazolidinones of formula (I) and B) other active ingredients, to a method for producing said combinations and to the use thereof as medicaments, in particular for the treatment and/or prophylaxis of thrombo-embolic diseases.
Term
Term ended
Projected expiry passed 7 June 2022, 4.3 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
8 priority claims, no other members on record
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 10129725 | Germany | A | |
| 10129725 | Germany | A | |
| 0206237 | European Patent Office (EPO) | W | |
| 0206237 | European Patent Office (EPO) | W | |
| 0110129725 | – | – | – |
| 02EP0206237 | – | – | – |
| DE2001129725 | – | – | – |
| WO2002EP06237 | – | – | – |
Numbers
- Publication, DOCDB
- 368079
- Publication, EPODOC
- PL368079
- Application
- 2368079
- Application, DOCDB
- 36807902
- Application, EPODOC
- PL20020368079
Titles2
- English
- SUBSTITUTED OXAZOLIDINONES FOR COMBINATIONAL THERAPY
- Polish
- Podstawione oksazolidynony do leczenia skojarzonego
Classification
- CPC, 13
- A61K31/422
- A61K31/5377
- A61K31/421
- A61K45/06
- A61P3/06
- A61P43/00
- A61P7/00
- A61P7/02
- A61P7/12
- A61P9/00
- A61P9/04
- A61P9/08
- A61P9/10
- IPC, 30
- A61K31 421
- A61K31 422
- C07D413 12
- A61K31 423
- A61K31 427
- A61K31 428
- A61K31 435
- A61K31 4365
- A61K31 4439
- A61K31 444
- A61K31 454
- A61K31 496
- A61K31 535
- A61K31 5355
- A61K31 5377
- A61K31 538
- A61K31 5383
- A61K31 541
- A61K45 00
- A61K45 06
- A61P7 02
- A61P9 00
- A61P9 04
- A61P9 08
- A61P9 10
- A61P43 00
- C07D413 14
- C07D417 14
- C07D495 04
- C07D498 04